From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
Toxicity
None
Grade 1
Grade 2
Grade 3
Grade 4
Anemia
0
1
Neutropenia
7
Thrombocytopenia
4
2